Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)
EUR 60.35
(0.58%)
EUR 60.35
(0.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 69.78 Million EUR | 10.54% |
| 2022 | 63.12 Million EUR | 11.02% |
| 2021 | 56.85 Million EUR | 14.12% |
| 2020 | 49.82 Million EUR | -6.91% |
| 2019 | 53.52 Million EUR | 1.16% |
| 2018 | 52.9 Million EUR | 13.83% |
| 2017 | 46.47 Million EUR | -8.38% |
| 2016 | 50.73 Million EUR | 10.09% |
| 2015 | 46.08 Million EUR | -10.53% |
| 2014 | 51.5 Million EUR | 10.98% |
| 2013 | 46.41 Million EUR | 2.34% |
| 2012 | 45.35 Million EUR | 9.11% |
| 2011 | 41.56 Million EUR | 5.29% |
| 2010 | 39.47 Million EUR | 10.7% |
| 2009 | 35.66 Million EUR | 45.14% |
| 2008 | 24.57 Million EUR | 352.36% |
| 2007 | -9.73 Million EUR | -17.67% |
| 2006 | -8.27 Million EUR | -151.86% |
| 2005 | 15.95 Million EUR | 24.09% |
| 2004 | 12.85 Million EUR | 14.19% |
| 2003 | 11.26 Million EUR | -15.17% |
| 2002 | 13.27 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 17.69 Million EUR | 29.67% |
| 2024 Q2 | 60.3 Million EUR | 240.81% |
| 2024 Q3 | 54.6 Million EUR | -69.13% |
| 2023 FY | 69.78 Million EUR | 10.54% |
| 2023 Q4 | 13.64 Million EUR | -29.85% |
| 2023 Q3 | 19.45 Million EUR | 1.86% |
| 2023 Q2 | 19.09 Million EUR | 5.25% |
| 2023 Q1 | 18.14 Million EUR | 31.87% |
| 2022 Q1 | 16.23 Million EUR | -35.54% |
| 2022 FY | 63.12 Million EUR | 11.02% |
| 2022 Q4 | 13.75 Million EUR | -18.24% |
| 2022 Q2 | 16.3 Million EUR | 0.39% |
| 2022 Q3 | 16.82 Million EUR | 3.21% |
| 2021 FY | 56.85 Million EUR | 14.12% |
| 2021 Q1 | 3.71 Million EUR | -78.33% |
| 2021 Q2 | 14.95 Million EUR | 302.31% |
| 2021 Q3 | 13 Million EUR | -13.04% |
| 2021 Q4 | 25.19 Million EUR | 93.76% |
| 2020 Q3 | 10.72 Million EUR | 19.94% |
| 2020 FY | 49.82 Million EUR | -6.91% |
| 2020 Q1 | 13 Million EUR | -10.04% |
| 2020 Q4 | 17.15 Million EUR | 59.92% |
| 2020 Q2 | 8.94 Million EUR | -31.25% |
| 2019 Q3 | 12.28 Million EUR | -11.3% |
| 2019 Q2 | 13.85 Million EUR | 7.23% |
| 2019 Q1 | 12.92 Million EUR | -21.66% |
| 2019 FY | 53.52 Million EUR | 1.16% |
| 2019 Q4 | 14.45 Million EUR | 17.65% |
| 2018 Q2 | 12.28 Million EUR | 11.76% |
| 2018 FY | 52.9 Million EUR | 13.83% |
| 2018 Q4 | 16.49 Million EUR | 25.52% |
| 2018 Q1 | 10.99 Million EUR | -23.01% |
| 2018 Q3 | 13.13 Million EUR | 6.95% |
| 2017 Q1 | 12.19 Million EUR | -22.06% |
| 2017 FY | 46.47 Million EUR | -8.38% |
| 2017 Q4 | 14.27 Million EUR | 30.61% |
| 2017 Q3 | 10.93 Million EUR | 20.44% |
| 2017 Q2 | 9.07 Million EUR | -25.58% |
| 2016 FY | 50.73 Million EUR | 10.09% |
| 2016 Q2 | 10.4 Million EUR | -17.6% |
| 2016 Q3 | 12.13 Million EUR | 16.68% |
| 2016 Q1 | 12.62 Million EUR | -7.93% |
| 2016 Q4 | 15.64 Million EUR | 28.94% |
| 2015 Q3 | 12.57 Million EUR | 96.47% |
| 2015 FY | 46.08 Million EUR | -10.53% |
| 2015 Q4 | 13.7 Million EUR | 8.98% |
| 2015 Q2 | 6.4 Million EUR | -52.2% |
| 2015 Q1 | 13.39 Million EUR | -9.35% |
| 2014 Q2 | 12.16 Million EUR | -0.47% |
| 2014 Q1 | 12.22 Million EUR | -13.92% |
| 2014 FY | 51.5 Million EUR | 10.98% |
| 2014 Q3 | 12.34 Million EUR | 1.45% |
| 2014 Q4 | 14.77 Million EUR | 19.7% |
| 2013 FY | 46.41 Million EUR | 2.34% |
| 2013 Q1 | 9.81 Million EUR | -21.93% |
| 2013 Q2 | 10.75 Million EUR | 9.66% |
| 2013 Q3 | 11.64 Million EUR | 8.25% |
| 2013 Q4 | 14.2 Million EUR | 21.93% |
| 2012 FY | 45.35 Million EUR | 9.11% |
| 2012 Q1 | 11.12 Million EUR | 2.71% |
| 2012 Q3 | 11.37 Million EUR | 10.6% |
| 2012 Q4 | 12.56 Million EUR | 10.42% |
| 2012 Q2 | 10.28 Million EUR | -7.49% |
| 2011 Q4 | 10.82 Million EUR | -2.42% |
| 2011 FY | 41.56 Million EUR | 5.29% |
| 2011 Q3 | 11.09 Million EUR | 10.96% |
| 2011 Q2 | 10 Million EUR | 3.73% |
| 2011 Q1 | 9.64 Million EUR | -16.72% |
| 2010 Q4 | 11.57 Million EUR | 29.08% |
| 2010 FY | 39.47 Million EUR | 10.7% |
| 2010 Q1 | 9.1 Million EUR | 50.45% |
| 2010 Q2 | 9.82 Million EUR | 7.95% |
| 2010 Q3 | 8.96 Million EUR | -8.74% |
| 2009 Q2 | 10.72 Million EUR | 16.09% |
| 2009 Q1 | 9.23 Million EUR | 0.0% |
| 2009 FY | 35.66 Million EUR | 45.14% |
| 2009 Q4 | 6.05 Million EUR | -37.33% |
| 2009 Q3 | 9.65 Million EUR | -9.93% |
| 2008 FY | 24.57 Million EUR | 352.36% |
| 2007 FY | -9.73 Million EUR | -17.67% |
| 2006 FY | -8.27 Million EUR | -151.86% |
| 2005 FY | 15.95 Million EUR | 24.09% |
| 2004 FY | 12.85 Million EUR | 14.19% |
| 2003 FY | 11.26 Million EUR | -15.17% |
| 2002 FY | 13.27 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| aap Implantate AG | 14.9 Million EUR | -368.134% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 94.584% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 94.584% |
| elexxion AG | 476.21 Thousand EUR | -14553.199% |
| Geratherm Medical AG | 14.12 Million EUR | -394.144% |
| Koninklijke Philips N.V. | 7.56 Billion EUR | 99.077% |
| Stratec SE | 41.95 Million EUR | -66.313% |
| Siemens Healthineers AG | 5.59 Billion EUR | 98.754% |